Neuron Specific Enolase, CSF
Also known as: NSE C
Use
Use to detect neuron specific enolase, which may be a nonspecific marker of neuronal damage. Neuron specific enolase is a marker used in clinical settings to assess potential neuronal damage. Its presence can indicate neuronal damage but is not definitive for malignant disease.
Special Instructions
This test uses the BRAHMS NSE Kryptor Immunoassay. It is essential that results obtained with different assay methods or kits are not used interchangeably. The test is performed on specific weekdays, namely Mon, Wed, and Fri.
Limitations
Results from this test cannot be interpreted as absolute evidence of the presence or absence of malignant disease. This assay's results are not comparable across different methodologies or kits, and care should be taken to avoid repeated freeze/thaw cycles which may affect sample integrity.
New York Approved
Methodology
Immunoassay (Quantitative Immunoassay)
Biomarkers
LOINC Codes
- 47053-4
- 47053-4
Result Turnaround Time
1-8 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
0.5 mL
Minimum Volume
0.5 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate from cells within 1 hour of collection. Transfer 0.5 mL CSF to an ARUP Standard Transport Tube.
Storage Instructions
Refrigerated
Causes for Rejection
Hemolyzed specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 1 week |
| Frozen | 1 year |